Key Takeaways
- • Six states enacted nine healthcare oversight laws as of August 2026, with California and Oregon implementing major legislation passed in 2025, signaling accelerating state-level regulatory momentum against private equity control structures in healthcare.
- • Private equity now controls over 550 hospitals—approximately 1 in 8 private, non-government hospitals in the United States—following 1,029 PE-backed healthcare deals tracked in 2025, establishing deep market penetration that regulatory bodies are now targeting.
- • State policy focus has expanded beyond simple acquisition notifications to scrutinize complex control mechanisms including management services organizations, debt arrangements, real estate holdings, joint ventures, and multi-tier ownership structures that obscure PE influence.
- • Michael Fenne of the Private Equity Stakeholder Project emphasized that the strongest emerging policies recognize PE influence operates through multiple financial channels beyond direct ownership, revealing regulatory gaps in how states currently monitor healthcare provider control.
- • Pending legislation in Massachusetts, New Jersey, and other states indicates further regulatory expansion is likely, with policy debates moving from whether acquisitions should trigger oversight to how regulators can achieve full visibility into PE transaction structures.
Summary
State legislators are substantially increasing regulatory scrutiny of private equity's role in healthcare, according to a September 2026 report from the Private Equity Stakeholder Project. The 2026 State Healthcare Policy Review documents a significant shift in how states are approaching PE oversight, moving beyond basic acquisition disclosure requirements toward comprehensive examination of the mechanisms through which PE firms exercise control over healthcare providers.
As of August 2026, six states had enacted nine laws addressing PE healthcare investments, while two major state programs—California and Oregon's legislation passed in 2025—entered implementation phases. This legislative activity reflects growing concern about the depth of PE penetration in the healthcare sector. Private equity firms now control over 550 hospitals, representing nearly 12.5% of all private, non-government hospitals in the United States. The Private Equity Stakeholder Project tracked 1,029 PE-backed healthcare deals in 2025 alone, underscoring the scale of PE involvement in healthcare transactions.
The evolution of state policy represents a conceptual shift in regulatory approach. Early state efforts focused on requiring advance notice of hospital acquisitions, but current policy debates have broadened considerably. State lawmakers are now examining how PE firms exercise influence through management services organizations, debt structures, real estate arrangements, joint ventures, and entities positioned higher in provider ownership hierarchies—control mechanisms that traditional acquisition oversight may miss entirely. Michael Fenne, Senior Policy Coordinator at PESP, noted that "the strongest policies recognize that influence over a healthcare provider can exist through ownership, management agreements, debt, real estate, joint ventures, and other financial arrangements," indicating that regulators are increasingly aware of PE's multifaceted control strategies.
The regulatory landscape continues to expand, with additional legislation reportedly under consideration in Massachusetts, New Jersey, and other jurisdictions. This acceleration suggests that state-level scrutiny of private equity in healthcare will intensify over coming months, with potential implications for future deal structuring and the cost of capital for PE healthcare investments. The gap between current oversight mechanisms and comprehensive regulatory visibility remains substantial, creating both compliance challenges and opportunities for further legislative development across state systems.
As of August 2026, six states had enacted nine laws addressing PE healthcare investments, while two major state programs—California and Oregon's legislation passed in 2025—entered implementation phases. This legislative activity reflects growing concern about the depth of PE penetration in the healthcare sector. Private equity firms now control over 550 hospitals, representing nearly 12.5% of all private, non-government hospitals in the United States. The Private Equity Stakeholder Project tracked 1,029 PE-backed healthcare deals in 2025 alone, underscoring the scale of PE involvement in healthcare transactions.
The evolution of state policy represents a conceptual shift in regulatory approach. Early state efforts focused on requiring advance notice of hospital acquisitions, but current policy debates have broadened considerably. State lawmakers are now examining how PE firms exercise influence through management services organizations, debt structures, real estate arrangements, joint ventures, and entities positioned higher in provider ownership hierarchies—control mechanisms that traditional acquisition oversight may miss entirely. Michael Fenne, Senior Policy Coordinator at PESP, noted that "the strongest policies recognize that influence over a healthcare provider can exist through ownership, management agreements, debt, real estate, joint ventures, and other financial arrangements," indicating that regulators are increasingly aware of PE's multifaceted control strategies.
The regulatory landscape continues to expand, with additional legislation reportedly under consideration in Massachusetts, New Jersey, and other jurisdictions. This acceleration suggests that state-level scrutiny of private equity in healthcare will intensify over coming months, with potential implications for future deal structuring and the cost of capital for PE healthcare investments. The gap between current oversight mechanisms and comprehensive regulatory visibility remains substantial, creating both compliance challenges and opportunities for further legislative development across state systems.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.